Biodesix (BDSX) Preferred Stock Liabilities (2019 - 2020)
Biodesix's (BDSX) quarterly Preferred Stock Liabilities came in at $194.0 million in Q3 2020, little changed YoY from $194.0 million in Q4 2019, and little changed on a QoQ basis from $194.0 million in Q2 2020.
Biodesix (BDSX) Preferred Stock Liabilities (2019 - 2020) Analysis & Trends
Biodesix (BDSX) has 2 years of Preferred Stock Liabilities data on file, last reported at $194.0 million in Q3 2020.
- Quarterly Preferred Stock Liabilities changed 0.0% year-over-year to $194.0 million in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $194.0 million (changed 0.0% YoY) and the FY2019 annual result came in at $194.0 million, changed N/A from the prior year.
- Preferred Stock Liabilities was little changed at $194.0 million in Q3 2020, from $194.0 million in the prior quarter.
- In the past five years, Preferred Stock Liabilities ranged from a high of $194.0 million in Q3 2019 to a low of $194.0 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | - |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | - |
| 10 | Biodesix | 220.74 Mn | 195.16 Mn | 21.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 193.96 Mn |
| Jun 30, 2020 | 193.96 Mn |
| Mar 31, 2020 | 193.96 Mn |
| Dec 31, 2019 | 193.96 Mn |
| Sep 30, 2019 | 193.96 Mn |